Seer, Inc. (SEER)
NASDAQ: SEER · Real-Time Price · USD
2.190
0.00 (0.00%)
At close: Aug 6, 2026, 4:00 PM EDT
2.154
-0.036 (-1.65%)
After-hours: Aug 6, 2026, 7:34 PM EDT
Seer, Inc. Market Cap
Seer, Inc. has a market cap or net worth of $120.41 million as of August 6, 2026. Its market cap has decreased by -3.48% in one year.
Market Cap
120.41M
Enterprise Value
-22.68M
1-Year Change
-3.48%
Ranking
Category
Stock Price
$2.19
ChartMarket Cap Chart
Since the IPO on December 4, 2020, Seer, Inc.'s market cap has decreased from $3.27B to $120.41M, a decrease of -96.32%. That is a compound annual growth rate of -44.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 120.41M | 16.97% |
| Dec 31, 2025 | 102.94M | -24.43% |
| Dec 31, 2024 | 136.21M | 10.01% |
| Dec 29, 2023 | 123.82M | -65.92% |
| Dec 30, 2022 | 363.32M | -74.19% |
| Dec 31, 2021 | 1.41B | -57.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NRx Pharmaceuticals | 129.50M |
| Spruce Biosciences | 127.76M |
| Tiziana Life Sciences | 125.98M |
| enGene Therapeutics | 120.58M |
| Genelux | 119.90M |
| ProMIS Neurosciences | 119.54M |
| Vivani Medical | 117.28M |
| Anixa Biosciences | 116.70M |